NK-92
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 16 Aug 2025)
What this means for you
Registered since 10 Jul 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87701224
- Registration number
- 5512531
- Mark type
- Stylized text
- Filed
- 29 Nov 2017
- Published for opposition
- 24 Apr 2018
- Registered
- 10 Jul 2018
- Attorney of record
- Alicia M. Passerin
Goods and services
- Class 001 — Chemicals: Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes
- Class 005 — Pharmaceuticals: [ Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes ]
- Class 042 — Scientific and technological services: Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto
Owner
- IMMUNITYBIO, INC., SAN DIEGO, CA, US
- NantKwest, Inc., Culver City, CA, US
- NantKwest, Inc., Culver City, CA, US
- NantKwest, Inc., Culver City, CA, US
Prosecution history
- 16 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Aug 2025 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 20 Nov 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 20 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 10 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 24 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Apr 2018 — PUBLISHED FOR OPPOSITION
- 04 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2018 — ASSIGNED TO EXAMINER
- 09 Dec 2017 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED